Geraldine Dawson


Geraldine Dawson, Ph.D. is an American child clinical psychologist, specializing in autism. She has conducted extensive research on early detection, brain development, and treatment of autism spectrum disorders and collaborated on studies of genetic risk factors in autism. Dawson is William Cleland Distinguished Professor of Psychiatry and Behavioral Sciences and Professor of Psychology and Neuroscience, Director, Duke Institute for Brain Sciences and Director of the Duke Center for Autism and Brain Development at Duke University Medical Center. Dawson is Past-President of the International Society for Autism Research, a scientific and professional organization devoted to advancing knowledge about autism spectrum disorders. From 2008–2013, Dawson was Research Professor of Psychiatry at the University of North Carolina at Chapel Hill and was Chief Science Officer for Autism Speaks. Dawson also held the position of Adjunct Professor of Psychiatry at Columbia University and is Professor Emerita of Psychology at University of Washington. She is a Fellow of the American Psychological Society, American Psychological Association, and the Society of Clinical Child and Adolescent Psychology.

Education

Dawson received her Bachelor of Science degree in psychology from the University of Washington in 1974 and her Ph.D. in developmental psychology and child clinical psychology from the University of Washington in 1979. In 1980, she was a postdoctoral fellow and clinical intern at the UCLA Neuropsychiatric Institute, where she specialized in neurodevelopmental disorders. She became a licensed practicing child clinical psychologist in 1980.

Career

Dawson has had a career as a scientist and practicing clinical psychologist focusing on autism spectrum disorders and child psychopathology. She has published extensively in peer-reviewed scientific journals on autism and the effects of early experience on the developing brain.
Dawson is currently William Cleland Distinguished Professor of Psychiatry, Director of the Duke Institute for Brain Sciences, and Founding Director of the Duke Center for Autism and Brain Development. Early in her career, Dawson was an assistant professor of child clinical psychology at the University of North Carolina at Chapel Hill and affiliate of the TEACCH program from 1980–1985. In 1985, she returned to her alma mater to join the psychology department faculty, where she directed the University of Washington Child Clinical Psychology Program. From 1996–2008, Dawson was Founding Director of the University of Washington Autism Center, which worked with Microsoft Corporation to set a precedent for companies to provide insurance coverage for autism early intervention. At the UW Autism Center, she was director of three NIH Autism Center of Excellence Awards, which provided funding for a multimillion-dollar multi-disciplinary autism research program focusing on genetics, neuroimaging, early diagnosis, and treatment. Dawson also founded and oversaw an endowed treatment center for autistic children and adolescents at the UW Autism Center, which provided multi-disciplinary diagnostic and treatment services for autistic children from infancy through late adolescence. Dawson has served as Associate Editor or Editorial Board Member for seven scientific journals: Clinical Psychological Science, Journal of Autism and Developmental Disorders, Development and Psychopathology, Psychophysiology, Autism Research, Autism Research and Treatment, and the Journal of Neurodevelopmental Disorders.
Dawson's research has focused on early detection and intervention, brain dysfunction, and genetic studies. Her key scientific discoveries include demonstrating that maternal depression can influence early brain activity and stress responses of infants and children, the detection of autism symptoms in infants, empirical validation of autistic regression, and elucidation of the nature of early brain dysfunction in autism. Dawson pioneered the use of home videotapes to study early symptoms of autism and the use of electrophysiological techniques to study brain function in very young children with autism. Dawson's lab at the University of Washington discovered differences in brain circuitry related to face processing in autism, apparent even before symptom onset, and defined a lifelong brain characteristic that was accepted in the FDA's Biomarker Qualification Program. In collaboration with Dr. Sally J. Rogers, Dawson developed and empirically validated the Early Start Denver Model, the first comprehensive early intervention program for very young children with autism.

Autism Speaks

Dawson received continuous NIH funding for her research from 1980–2008 when she left her tenured faculty position at the University of Washington to become Autism Speaks' first chief science officer. At Autism Speaks, Dawson oversaw $20–30 million in annual research funding, including funding for the Autism Treatment Network, the Autism Genetic Resource Exchange, the Autism Genome Project, and the Autism Tissue Program. Under her leadership at Autism Speaks, several new initiatives were launched, including the Translational Medicine Research Initiative, Postdoctoral Research Fellowship, the Trailblazer Award, the Autism 10K Genome Project, the Early Access to Care Initiative, the Global Autism Public Health Initiative, and DELSIA, a not-for-profit affiliate of Autism Speaks focused on accelerating scientific breakthroughs through partnerships with industry. In 2008, Dawson was featured in the journal, Science, when she began her new role at Autism Speaks.

Media and popular press coverage

Dawson's work has been featured frequently in the media, including programs such as the Jim Lehrer Newshour, PBS Scientific American Frontiers with Alan Alda, The New York Times, among many others. Her research demonstrating that early intervention can normalize brain activity in children with autism was recognized by TIME magazine as one of the top 10 medical breakthroughs of 2012. The Early Start Denver Model is described in the January 2014 issue of Scientific American Mind. Dawson's scientific research was recognized by the National Institutes of Health as a Top Advance in Autism Research in 2007, 2008, 2009, 2010, 2012, 2013, 2015, 2016, 2017 and 2018.
Dawson has testified before the United States Senate to advocate for autistic individuals and their families: in 1999 in support of the Child Health Act of 2000, in 2002 on behalf of the Federation of Behavioral, Psychological, and Cognitive Sciences, in 2009 at the request of the Senate to provide an update on the current state of autism science, and in 2012 in support of a bill to increase access to autism services for military families.

Honors, awards, and appointments

Dawson's honors and awards include the Association for Psychological Science James McKeen Cattell Lifetime Achievement Award, American Psychological Association Distinguished Career Award, Top 1% Most-Cited Researcher Across All Fields, Clarivate Analytics, Tarheel of the Week, Geoffrey Beene Rock Star of Science Award, Autism Hero Award from the Cure Autism Now Foundation, Autism Society of America Award for Research Contributions to the Autism Community, Autism Society of Washington Medical Professional of the Year, Washington Autism Society Achievement Award for Outstanding Service, Autism Society of America Award for Valuable Service and the Gatzert Child Welfare Award. Dawson has been an advisor to the National Institutes of Health since 1989.
She has been a long-standing member of the National Institutes of Health Interagency Autism Coordinating Committee, a federal advisory committee that coordinates all efforts within the Department of Health and Human Services concerning Autism Spectrum Disorders. In 2013–2014, she served on the autism practice guidelines committee for the American Academy of Neurology. From 1998–1999, she served on the NIH Committee on Practice Parameters for Screening and Diagnosis of Autism. From 2001–2002, she was a member of the NIH Committee on Practice Parameters for Treatment of Autism. From 2003–2007, she was a member of the NIH Scientific Advisory Panel to establish a 10-year road map for autism research. In 2008, she chaired the NIH Scientific Advisory Panel's subcommittee on Autism Treatment Research. Dawson also served on the NIH Consensus Panel on Phenylketonuria. Dawson has served on the NIH Child Psychopathology and Treatment Grant Review Committee, the NIMH Grant Review Biological and Neurological Subcommittee, and the NIMH Grant Review Committee for Behavioral Science. She also served on the steering committees for the NIH Collaborative Program of Excellence in Autism, the NIH Studies to Accelerate Autism Research and Treatment Program, and the NIH Autism Centers of Excellence Program.

Representative Publications

Books